What was Animalcare Group PLC’s price range in the past 12 months?
Animalcare Group PLC lowest share price was 143.08p and its highest was 278.02p in the past 12 months.
What is Animalcare Group PLC’s market cap?
Currently, no data Available
When is Animalcare Group PLC’s upcoming earnings report date?
Animalcare Group PLC’s upcoming earnings report date is Mar 26, 2024 which is in 180 days.
How were Animalcare Group PLC’s earnings last quarter?
Animalcare Group PLC released its earnings results on Sep 26, 2023. The company reported 0.027p earnings per share for the quarter, beating the consensus estimate of N/A by 0.027p.
Animalcare Group PLC pays a Annually dividend of 2.4p which represents an annual dividend yield of 2.38%. See more information on Animalcare Group PLC dividends here
What is Animalcare Group PLC’s EPS estimate?
Animalcare Group PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Animalcare Group PLC have?
Animalcare Group PLC has 60,097,622 shares outstanding.
What happened to Animalcare Group PLC’s price movement after its last earnings report?
Animalcare Group PLC reported an EPS of 0.027p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.37%.
Which hedge fund is a major shareholder of Animalcare Group PLC?
Currently, no hedge funds are holding shares in GB:ANCR
The Animalcare Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is one of the leading generic veterinary medicines companies. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. Its only reportable segment is Pharmaceutical which includes the development and marketing of innovative pharmaceutical products. The company has a presence in Belgium, Spain, Portugal, the United Kingdom, and Other Countries of which Spain derives a majority of revenue to the company.